中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus

文献类型:期刊论文

作者Zhang, Yumin4; Tang, Sheng4; Chen, Lu1,4; Song, Shufen4; Cao, Junyuan4; Tian, Guanghui3; Xiao, Gengfu1,4; Shen, Jingshan2; Zhang, Leike1,4
刊名SIGNAL TRANSDUCTION AND TARGETED THERAPY
出版日期2026-02-11
卷号11期号:1页码:3
ISSN号2095-9907
DOI10.1038/s41392-025-02567-3
资助项目Major Project of Guangzhou National Laboratory (GZNL2024A01008 to G. Xiao) ; Strategic Priority Research Program of Chinese Academy of Sciences (XDB0490000 to L. Zhang) National Key Research and Development Plan of China (2022YFC2303300 to L. Zhang) Key R&D Program of Hubei Province (2021BCD004 to L. Zhang). ; National Natural Science Foundation of China (National Science Foundation of China)[U22A20379]
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology
语种英语
WOS记录号WOS:001687088100002
出版者SPRINGERNATURE
源URL[http://119.78.100.183/handle/2S10ELR8/322972]  
专题国家级研究中心_原创新药研究全国重点实验室
通讯作者Xiao, Gengfu; Shen, Jingshan; Zhang, Leike
作者单位1.Univ Chinese Acad Sci, Beijing, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
3.Vigonvita Shanghai Co Ltd, Shanghai, Peoples R China
4.Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Megasci, State Key Lab Virol & Biosafety, Wuhan, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Yumin,Tang, Sheng,Chen, Lu,et al. Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2026,11(1):3.
APA Zhang, Yumin.,Tang, Sheng.,Chen, Lu.,Song, Shufen.,Cao, Junyuan.,...&Zhang, Leike.(2026).Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.SIGNAL TRANSDUCTION AND TARGETED THERAPY,11(1),3.
MLA Zhang, Yumin,et al."Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus".SIGNAL TRANSDUCTION AND TARGETED THERAPY 11.1(2026):3.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。